Clinical Trial Update: the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

A trial update for Rulonilimab in combination with Lenvatinib in hepatocellular carcinoma is in Phase 2 and Phase 3 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Lenvatinib (lenvatinib)
• Rulonilimab (Rulonilimab)

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: RECRUITING